Anika Therapeutics (ANIK) Operating Margin (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Operating Margin of 9.06% for Q2 2026, up 2387.0% year-over-year from 0.36% in Q2 2025, and up 148.88% quarter-over-quarter from 18.53% in Q1 2026.
Anika Therapeutics (ANIK) Operating Margin (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Operating Margin for 17 consecutive years, with 9.06% the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Margin rose 2387.0% year-over-year to 9.06%; the TTM figure through Jun 2026 stood at 4.24% (up 383.0% YoY), while the FY2025 annual figure was 9.8%, down 554.0% from the prior year.
- Operating Margin grew to 9.06% in Q2 2026 per ANIK's latest filing, from 18.53% in the prior quarter.
- Across five years, Operating Margin topped out at 9.06% in Q2 2026 and bottomed at 852.09% in Q4 2023.
- Historically, Operating Margin has averaged 88.91% across 5 years, with a median of 10.65% in 2022.
- Annual changes were most pronounced in 2022 — Operating Margin tumbled 56309 bps — and 2024, when it surged 84978 bps.
- Anika Therapeutics' Operating Margin stood at 588.55% in 2022, then slumped by 45 bps to 852.09% in 2023, then jumped by 100 bps to 2.3% in 2024, then soared by 192 bps to 2.11% in 2025, then surged by 329 bps to 9.06% in 2026.
- Business Quant data shows ANIK's Operating Margin at 9.06% in Q2 2026, 18.53% in Q1 2026, and 2.11% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 9.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.06% |
| Mar 31, 2026 | -18.53% |
| Dec 31, 2025 | 2.11% |
| Sep 30, 2025 | -11.62% |
| Jun 30, 2025 | -14.81% |
| Mar 31, 2025 | -16.37% |
| Dec 31, 2024 | -2.30% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | -5.89% |
| Mar 31, 2024 | -8.63% |
| Dec 31, 2023 | -852.09% |
| Sep 30, 2023 | -18.51% |
| Jun 30, 2023 | -8.20% |
| Mar 31, 2023 | -33.10% |
| Dec 31, 2022 | -588.55% |
| Sep 30, 2022 | -14.40% |
| Jun 30, 2022 | -8.53% |
| Mar 31, 2022 | -9.69% |
| Dec 31, 2021 | -25.47% |
| Sep 30, 2021 | 3.29% |